ETEX' bone substitute material cleared for new indication:
This article was originally published in Clinica
The US FDA has cleared ETEX' alpha-BSM for use in the repair and reconstruction of bones in the cheek, chin, face and cranium. The bone substitute material is made from calcium phosphate and has an endothermic hardening property which allows it to remain a moldable or injectable putty at room temperature and harden only in situ at body temperature. Alpha-BSM has been previously cleared for dental and peridontal indications.
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.